FDA ‘remains unsatisfied’ in Philips Respironics ventilator, sleep apnea device recall

The FDA asked for more testing regarding the recall of certain Philips Respironics ventilators, bilevel positive airway pressure machines and continuous positive airway pressure machines, according to an update from the agency.
“The FDA remains unsatisfied with the status of this recall, and we continue to take steps to protect the health and safety of individuals using these devices,” Jeff Shuren, MD, JD, director of the FDA's Center for Devices and Radiological Health, said in a statement.
In June 2021, the FDA issued an alert that Philips Respironics recalled 15 million

The FDA asked for more testing regarding the recall of certain Philips Respironics ventilators, bilevel positive airway pressure machines and continuous positive airway pressure machines, according to an update from the agency.
“The FDA remains unsatisfied with the status of this recall, and we continue to take steps to protect the health and safety of individuals using these devices,” Jeff Shuren, MD, JD, director of the FDA’s Center for Devices and Radiological Health, said in a statement.
In June 2021, the FDA issued an alert that Philips Respironics recalled 15 million